Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1173-1182

  Adam, Jean François ^a   Biston, Marie Claude ^a   Joubert, Aurélie ^a   Charvet, Anne Marie ^a   Le Bas, Jean François ^a,b   Estève, François ^a,b   Elleaume, Hélène ^a,c  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Blood brain barrier disruption; Brain tumors; Iodine; Stereotactic radiotherapy; Synchrotron radiation

Indexed keywords

BLOOD; BRAIN; COMPUTER SIMULATION; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; PATIENT TREATMENT; PHYSIOLOGICAL MODELS; RADIOTHERAPY; TUMORS; X RAY ANALYSIS;

BLOOD-BRAIN BARRIER; DOSE ENHANCEMENT FACTORS (DEF); INTRACAROTID (IC); MANNITOL; SYNCHROTON STEREOTACTIC RADIOTHERAPY (SSR);

IODINE;

IOMEPROL; MANNITOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER MODEL; CANCER RADIOTHERAPY; CEREBELLUM; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG UPTAKE; JUGULAR VEIN; MALE; MICRODOSIMETRY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RAT; SYNCHROTRON RADIATION; SYNCHROTRON STEREOTACTIC RADIOTHERAPY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; GLIOMA; IODINE RADIOISOTOPES; MALE; MANNITOL; RATS; RATS, INBRED F344; SYNCHROTRONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 14844322179     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.12.026     Document Type: Article

References (37)

1. R.F. Barth, W.L. Yang, J.H. Rotaru Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption Cancer Res 57 1997 1129 1136
2. M.H. Phillips, K.J. Stelzer, T.W. Griffin Stereotactic radiosurgery: A review and comparison of methods J Clin Oncol 12 1994 1085 1099
3. R.M. Cardinale, S.H. Benedict, Q. Wu A comparison of three stereotactic radiotherapy techniques: ARCS vs. noncoplanar fixed fields vs intensity modulation. Int J Radiat Oncol Biol Phys 42 1998 431 436
4. J.H. Rose, A. Norman, M. Ingram First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx) Int J Radiat Oncol Biol Phys 45 1999 1127 1132
5. R. Santos Mello, H. Callisen, J. Winter Radiation dose enhancement in tumors with iodine Med Phys 10 1983 75 78
6. P. Dawson, M. Penhaligon, E. Smith Iodinated contrast agents as "radiosensitizers." Br J Radiol 60 1987 201 203
7. P. Dawson, M. Penhaligon, E. Smith Synergistic cytotoxicity of iodinated contrast agents and X-radiation Invest Radiol 23 Suppl 1 1988 S110 S113
8. F. Estève, S. Corde, H. Elleaume Enhanced radio sensitivity with iodinated contrast agents using monochromatic synchrotron X-rays on human cancerous cells Acad Radiol 9 2002 S540 S543
9. S. Corde, A. Joubert, J.F. Adam Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds Br J Cancer 91 2004 544 551
10. K.S. Iwamoto, S.T. Cochran, J. Winter Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors Radiother Oncol 8 1987 161 170
11. K.S. Iwamoto, A. Norman, D.B. Freshwater Diagnosis and treatment of spontaneous canine brain tumors with a CT scanner Radiother Oncol 26 1993 76 78
12. A. Norman, M. Ingram, R.G. Skillen X-ray phototherapy for canine brain masses Radiat Oncol Investig 5 1997 8 14
13. S. Matsubara, T. Katoh, N. Kubota The effects of x-ray energy and an iodine-based contrast agent on chromosome aberrations Radiat Res 137 1994 231 237
14. S. Matsubara, Z.S. Kong, M. Omura The effect of iodine-based contrast agents on the levels of radiation-induced chromosomal aberrations Radiat Res 147 1997 263 268
15. A.V. Mesa, A. Norman, T.D. Solberg Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents Phys Med Biol 44 1999 1955 1968
16. T.D. Solberg, K.S. Iwamoto, A. Norman Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours Phys Med Biol 37 1992 439 443
17. Solberg TD, Iwamoto KS, Norman A. Synchrotron radiation for dose enhancement therapy of brain tumors: Monte Carlo calculations [Abstract]. 40th Annual Meeting of the Radiation Research Society. 1992; Salt Lake City, UT.
18. J.F. Adam, H. Elleaume, A. Joubert Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas Int J Radiat Oncol Biol Phys 57 2003 1413 1426
19. R.F. Barth, W. Yang, R.T. Bartus Enhanced delivery of boronophenylalanine for neutron capture therapy using the Bradykinin analog Cereport (receptor-mediated permeabilizer-7) Neurosurgery 44 1999 351 360
20. S.I. Rapoport Osmotic opening of the blood-brain barrier: Principles, mechanism, and therapeutic applications Cell Mol Neurobiol 20 2000 217 230
21. S.I. Rapoport Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy Expert Opin Investig Drugs 10 2001 1809 1818
22. W. Yang, R.F. Barth, D.E. Carpenter Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption Neurosurgery 38 1996 985 992
23. W. Yang, R.F. Barth, J.H. Rotaru Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine J Neurooncol 33 1997 59 70
24. J.F. Adam, H. Elleaume, G. Le Duc Absolute cerebral blood volume and blood flow measurements based on synchrotron radiation quantitative computed tomography J Cereb Blood Flow Metab 23 2003 499 512
25. H. Elleaume, A.M. Charvet, S. Corde Performance of computed tomography for contrast agent concentration measurements with monochromatic x-ray beams: comparison of K-edge versus temporal subtraction Phys Med Biol 47 2002 3369 3385
26. A.L. Benabid, C. Remy, C. Chauvin Experimental model of rat brain tumors by stereotactic injection of C6 glioma and HTC hepatoma cell lines M.D. Walker D.G.T. Thomas Biology of brain tumors 1986 Martinus Nijhoff Publishers Amsterdam 221 226
27. R.F. Barth Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas J Neurooncol 36 1998 91 102
28. N.R. Clendenon, R.F. Barth, W.A. Gordon Boron neutron capture therapy of a rat glioma Neurosurgery 26 1990 47 55
29. J.J. Tzeng, R.F. Barth, C.G. Orosz Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors Cancer Res 51 1991 2373 2378
30. M.C. Biston, A. Joubert, J.F. Adam Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron x-rays Cancer Res 64 2004 2317 2323
31. D.E. Bullard, S.C. Saris, D.D. Bigner Carotid artery injections in 40- to 99-g Fischer rats: Technical note and evaluation of blood flow by various injection techniques Neurosurgery 14 1984 406 411
32. H. Elleaume, A.M. Charvet, P. Berkvens Instrumentation of the ESRF medical imaging facility Nucl Instrum Meth A 428 1999 513 527
33. W. Thomlinson, P. Berkvens, G. Berruyer Research at the European Synchrotron Radiation Facility medical beamline Cell Mol Biol 46 2000 1053 1063
34. F.A. Dilmanian, X.Y. Wu, E.C. Parsons Single and dual-energy CT with monochromatic synchrotron x-rays Phys Med Biol 42 1997 371 387
35. Herman GT, Lewitt RM, Ohdner D, Rowland SW. SNARK89: A programming system for image reconstruction from projections. Medical Image Processing Group. Technical Report No. 160. Philadelphia: University of Pennsylvania; 1989.
36. C.V. Borlongan, D.F. Emerich Facilitation of drug entry into the CNS via transient permeation of blood-brain barrier: Laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport Brain Res Bull 60 2003 297 306
37. D.F. Emerich, R.L. Dean, J. Marsh Intravenous Cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain Pharm Res 17 2000 1212 1219